Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT

There is no fulltext present in this item.

Title:	Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT
Author(s):	Wijsman, R.; Dankers, F.J.W.M.; Troost, E.G.; Hoffmann, A.L.; Heijden, E.H.F.M. van der ; Geus-Oei, L.F. de ; Bussink, J.
Publication year:	2017
Source:	Radiotherapy and Oncology, vol. 122, iss. 2, (2017), pp. 295-299
ISSN:	0167-8140
DOI:	https://doi.org/10.1016/j.radonc.2016.11.015
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/173063
Display more details
Subject:	Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences
Organization:	Radiation Oncology Pulmonary Diseases Radiology & Nuclear Medicine
Journal title:	Radiotherapy and Oncology
Volume:	vol. 122
Issue:	iss. 2
Page start:	p. 295
Page end:	p. 299
Abstract:	Retrospective evaluation of 188 advanced stage non-small cell lung cancer patients treated with IMRT or VMAT revealed a limited increase of moderate to severe acute esophageal toxicity after VMAT. Acute pulmonary toxicity and severe late toxicity were low. Overall survival did not differ between the IMRT and VMAT groups.